Liangliang Shi

6PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 10, 2026
Response-Adapted Surgery after Neoadjuvant Immunochemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma (REMATCH): A Single-Arm Phase II Trial.

|Jun 10, 2026
TQB2618 plus Penpulimab, Alone or in Combination with Chemotherapy, for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter, Two-Cohort, Phase II Trial.

|Aug 26, 2022
PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy.

Jun Li, Gang Peng, Kuikui Zhu

|Jan 24, 2022
Tumor factors associated with in-field failure for nasopharyngeal carcinoma after intensity-modulated radiotherapy.

Xixi Liu, Bian Wu, Jing Huang

|Aug 28, 2020
Effects of Apatinib on the "Stemness" of Non-Small-Cell Lung Cancer Cells In Vivo and Its Related Mechanisms.

Bin Yang, Yan Wang, Zhuoying Chen

|Aug 22, 2019
KCNN4 promotes invasion and metastasis through the MAPK/ERK pathway in hepatocellular carcinoma.

Qiu-Ting Li, Yi-Ming Feng, Zun-Hui Ke

Pageof 1

Frequent Collaborators

3 joint publications

Kunyu Yang

2 joint publications

Zhanjie Zhang

2 joint publications

Jing Huang

2 joint publications

Xiaohua Hong